MKI67 and breast carcinoma: Ki67, a key proliferation index biomarker, plays a pivotal role in various malignancies, particularly breast cancer, where it serves multiple functions, including prognostication, prediction of response to chemotherapy and endocrine therapy, and as a dynamic marker for NAC efficacy (32–35).